Literature DB >> 20217291

A teaching model for aromatase inhibitors after tamoxifen.

Theresa Trotter1, Marc Webster, Cindy Railton, A H G Paterson, Tyrone Donnon.   

Abstract

Breast cancer is the most common cancer diagnosed in women. The present study evaluated the family physicians' (FPs) understanding of adjuvant hormonal therapies for an early breast cancer. FPs were invited to attend teaching workshops on this topic, which utilized a pretest, didactic and interactive teaching, and posttest format. FPs (n = 23) showed an improvement (p < 0.001) in pretest to posttest score. It is clear that, with a targeted teaching, FPs can quickly become more knowledgeable on the topic of hormonal therapies in breast cancer, with the potential of applying this information in their own practice.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20217291     DOI： 10.1007/s13187-010-0095-9

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN： 0885-8195            Impact factor:   2.037


  11 in total

Review 1.  Continuing education meetings and workshops: effects on professional practice and health care outcomes.

Authors:  M A Thomson O'Brien; N Freemantle; A D Oxman; F Wolf; D A Davis; J Herrin
Journal:  Cochrane Database Syst Rev       Date:  2001

2.  Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.

Authors:  Raimund Jakesz; Walter Jonat; Michael Gnant; Martina Mittlboeck; Richard Greil; Christoph Tausch; Joern Hilfrich; Werner Kwasny; Christian Menzel; Hellmut Samonigg; Michael Seifert; Guenther Gademann; Manfred Kaufmann; Johann Wolfgang
Journal:  Lancet       Date:  2005 Aug 6-12       Impact factor: 79.321

3.  Comparison of the instructional efficacy of Internet-based CME with live interactive CME workshops: a randomized controlled trial.

Authors:  Michael Fordis; Jason E King; Christie M Ballantyne; Peter H Jones; Katharine H Schneider; Stephen J Spann; Stephen B Greenberg; Anthony J Greisinger
Journal:  JAMA       Date:  2005-09-07       Impact factor: 56.272

4.  Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial.

Authors:  F Boccardo; A Rubagotti; P Guglielmini; A Fini; G Paladini; M Mesiti; M Rinaldini; S Scali; M Porpiglia; C Benedetto; N Restuccia; F Buzzi; R Franchi; B Massidda; V Distante; D Amadori; P Sismondi
Journal:  Ann Oncol       Date:  2006-06       Impact factor: 32.976

5.  Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Authors:  A Howell; J Cuzick; M Baum; A Buzdar; M Dowsett; J F Forbes; G Hoctin-Boes; J Houghton; G Y Locker; J S Tobias
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

6.  Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?

Authors:  D Davis; M A O'Brien; N Freemantle; F M Wolf; P Mazmanian; A Taylor-Vaisey
Journal:  JAMA       Date:  1999-09-01       Impact factor: 56.272

7.  A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.

Authors:  Beat Thürlimann; Aparna Keshaviah; Alan S Coates; Henning Mouridsen; Louis Mauriac; John F Forbes; Robert Paridaens; Monica Castiglione-Gertsch; Richard D Gelber; Manuela Rabaglio; Ian Smith; Andrew Wardley; Andrew Wardly; Karen N Price; Aron Goldhirsch
Journal:  N Engl J Med       Date:  2005-12-29       Impact factor: 91.245

8.  Randomized trial of problem-based versus didactic seminars for disseminating evidence-based guidelines on asthma management to primary care physicians.

Authors:  Marc White; Gaëtane Michaud; George Pachev; David Lirenman; Anna Kolenc; J Mark FitzGerald
Journal:  J Contin Educ Health Prof       Date:  2004       Impact factor: 1.355

9.  A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

Authors:  Paul E Goss; James N Ingle; Silvana Martino; Nicholas J Robert; Hyman B Muss; Martine J Piccart; Monica Castiglione; Dongsheng Tu; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; Patrick Therasse; Michael J Palmer; Joseph L Pater
Journal:  N Engl J Med       Date:  2003-10-09       Impact factor: 91.245

10.  Changing physician prescribing patterns through problem-based learning: an interactive, teleconference case-based education program and review of problem-based learning.

Authors:  Ray S Davis; Don A Bukstein; Allan T Luskin; Josh A Kailin; Gail Goodenow
Journal:  Ann Allergy Asthma Immunol       Date:  2004-09       Impact factor: 6.347
View more
  1 in total

1.  Improving primary care in British Columbia, Canada: evaluation of a peer-to-peer continuing education program for family physicians.

Authors:  Dan MacCarthy; Liza Kallstrom; Helena Kadlec; Marcus Hollander
Journal:  BMC Med Educ       Date:  2012-11-09       Impact factor: 2.463
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.